The Decibel Why are drug deaths rising in Edmonton, but falling elsewhere?
20 snips
May 11, 2026 
Alanna Smith, a Globe and Mail health reporter who reported from Edmonton on rising drug deaths and harm reduction, shares on-the-ground observations. She contrasts national declines with Edmonton’s spike. She describes outreach shifts, dangerous drug mixes like Trankdope and carfentanil, policing effects, service gaps, and the politics shaping harm reduction.
AI Snips
Chapters
Transcript
Episode notes
National Decline Masks Local Variation
- National drug deaths fell sharply between 2023 and preliminary 2025 totals, roughly halving from over 8,000 to about 4,162 so far.
- Contributing factors include clampdowns on Chinese fentanyl supply, more naloxone access, shifts from injecting to snorting, and earlier high mortality among the most vulnerable.
Hands On Outreach With 4B Harm Reduction
- Alanna joined outreach group 4B Harm Reduction run by Angie Staines and toured encampment areas handing out sterile pipes, needles, cookers, snacks, bandages and cigarettes.
- Angie is a former LPN who provides wound care and carries naloxone; her program grew out of her son Brandon's experience and Brandon now volunteers in recovery.
Trankdope Reduces Naloxone Effectiveness
- Edmonton's drug supply increasingly contains dangerous mixes like Trankdope (opioids plus tranquilizers such as xylazine or metatomidine) that cause severe respiratory depression.
- Naloxone reverses opioids but not sedatives, so responders now often need multiple doses and patients remain deeply unresponsive.